The Bertarelli family made their vast fortune from drugs. They’re still betting the pharmaceutical industry can deliver.
Gurnet Point Capital, a health-care fund backed by Ernesto Bertarelli, Switzerland’s richest person, has agreed to buy Corium International Inc. in a deal that could value the Menlo Park, California-based biopharmaceutical company at more than $500 million.
By focusing on pharmaceuticals, Bertarelli is sticking to what he knows. He orchestrated the sale of the family’s fertility drug maker, Serono, to Merck & Co. for $8.6 billion in 2006 when he was 40 years old. Today, the family’s fortune is valued at $15.6 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.